2024年2月27日時点の情報

海外の感染症の最新の流行状況を情報をお知らせいたします。
※出典が海外のため原文のまま掲載しています。最新の記事はこちら

2024年2月27日時点の情報

Middle East Respiratory Syndrome Coronavirus |16 February 2024|Kingdom of Saudi Arabia
All four cases had co-morbidities and none were health care workers. Two cases were male and two female, ranging in age from 59 to 93 years. The cases developed symptoms, including fever, cough, and shortness of breath, between 15 September 2023 and 26 October 2023. The two deaths occurred on 19 October 2023 and 24 December 2023.

Avian Influenza A(H10N5) and Influenza A(H3N2) coinfection|13 February 2024|China
The case occurred in a female farmer over 60 years of age from Xuancheng Prefecture, Anhui Province, who had onset of symptoms of cough, sore throat and fever on 30 November 2023. The patient, who had a history of chronic comorbidities, was admitted to a local hospital on 2 December 2023 for treatment and was then transferred on 7 December 2023 to a medical institution in Zhejiang Province as her condition became more severe. The patient was diagnosed with influenza A virus infection. She passed away on 16 December 2023. Zhejiang Province health officials isolated seasonal influenza A(H3N2) subtype and avian influenza A(H10N5) subtype viruses from the patient’s samples on 22 January 2024 after nucleic acid testing, viral culture and gene sequencing conducted by local health care facilities.

Influenza A(H1N1) variant virus|9 February 2024|Spain
The patient, who has completely recovered, developed symptoms on 25 November 2023. These included fever, malaise, and cough. He first attended an outpatient clinic on 29 November 2023, and was seen again twice in December 2023, where he was diagnosed with bronchitis. He did not receive any antiviral treatment.

Western Equine Encephalitis|8 February 2024|Uruguay
The patient had onset of symptoms in the first days of January 2024, reporting headache, fever, photophobia and vomiting. Later the patient presented with deterioration of consciousness, and medical imaging patterns were compatible with encephalitis, requiring admission to intensive care for a few days. Currently the patient has recovered and has been discharged. (1)(2).

Avian Influenza A (H5N1)|8 February 2024|Cambodia
The first case, a 3-year-old, was reported on 26 January 2024, from Kampong Trabek district, Prey Veng province. The patient developed symptoms on 13 January 2024 and was admitted to hospital on 16 January 2024 with high fever, cough and runny nose. Samples were collected at the hospital and were transported to the National Institute of Public Health for testing. There, the samples tested positive for H5N1 through quantitative reverse transcription polymerase chain reaction (RT-qPCR) on 25 January 2024 and were confirmed by the Institut Pasteur du Cambodge (IPC) on 25 January 2024. The patient had a history of exposure to backyard chickens that were found dead around the residence. A total of 14 close contacts of the case were identified and samples were collected and tested, of which none were positive for influenza.

Influenza A (H1N1) variant virus|7 February 2024|Brazil
The patient is an adult male, with underlying medical conditions, who resides in the municipality of Toledo, in the State of Paraná. The man, who lives alone, had no history of exposure to pigs or to any ill individuals. From the epidemiological investigation, no close contacts were identified.

Public health risk assessment related to Western Equine Encephalitis (WEE) virus in the Region of the Americas – 23 February 2024|23 Feb 2024|Pan American Health Organization
Public health risk assessment related to Western Equine Encephalitis (WEE) virus in the Region of the Americas – 23 February 2024

Epidemiological Alert – Increase in dengue cases in the Region of the Americas – 16 February 2024|16 Feb 2024|Pan American Health Organization
Considering the number of dengue cases reported in the first weeks of 2024, with an exponential increase in several countries of the Region of the Americas, following a year in which the highest number of dengue cases reported in recent decades was recorded in the Americas, the Pan American Health Organization / World Health Organization (PAHO/WHO) reiterates to Member States the importance of intensifying efforts and actions to control the Aedes aegypti mosquito (the main vector of transmission), in addition to continuing with surveillance, early diagnosis, and the timely treatment of dengue cases.

Public Health Risk Assessment related to Oropouche Virus (OROV) in the Region of the Americas – 9 February 2024|9 Feb 2024|Pan American Health Organization
Public Health Risk Assessment related to Oropouche Virus (OROV) in the Region of the Americas – 9 February 2024

Epidemiological update – Western Equine Encephalitis in the Region of the Americas – 8 February 2024|8 Feb 2024|Pan American Health Organization
This epidemiological update provides new information on the WEE cases in the Americas, as well as surveillance guidance and the case definition for WEE in humans. As of 9 January 2024, there were 1,314 outbreaks in animals (1,258 in Argentina and 56 in Uruguay) reported and 21 cases of this virus in humans had been confirmed, including one death, all in Argentina. As of 5 February 2024, there were 2,438 outbreaks in animals (1,419 in Argentina, 1,018 in Uruguay, and one in Brazil) and 58 confirmed cases in humans (56 in Argentina and two in Uruguay) .
Source:https://www.paho.org//en/documents/epidemiological-update-western-equine-encephalitis-region-americas-8-february-2024

WHO Africa, UNICEF and Partners poised to advance implementation of Baby-Friendly Ho…|19 February 2024|African Region
In a concerted effort to strengthen maternal and child health services across Africa, the World Health Organization, in collaboration with the United Nations Children’s Fund (UNICEF) and the United States Agency for International Development (USAID), convened a capacity-building workshop targeting healthcare professionals, policymakers, and stakeholders from ten countries (Ethiopia, Ghana, Kenya, Malawi, Nigeria, South Sudan, Tanzania, Uganda, Zambia, and Zimbabwe).

Nearly 10 000 children vaccinated as malaria vaccine rollout in Africa expands|09 February 2024|African Region
Nearly 10 000 children in Burkina Faso and Cameroon have now received the RTS,S malaria vaccine since being introduced this year. A wider malaria vaccine rollout is underway this year in several African countries, with Cameroon being the first outside the malaria vaccine pilot programme to do so.